Neuralink plans to enroll participants from its ongoing PRIME trial into this feasibility study, as mentioned in a post on ...
Neuralink, which company received Food and Drug Administration clearance in May 2023 to launch human trials, has so far only ...
Like the US study, the CAN-PRIME Neuralink trial will only consider patients who can't use their hands and is designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback